Nanoparticle polymeric micellar paclitaxel (pm-Pac), platinum, and sintilimab as first-line treatment for…

A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131
Jennifer R. Eads, Ju-Whei Lee, Cheng E. Chee +6
Clinical colorectal cancer2 Sep 2026Peer-reviewedCC BY-NC-NDFull textOncologyPMC
Surufatinib and camrelizumab plus nab-paclitaxel–gemcitabine as first-line treatment for metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
Yudong Yuan, Dongdong Zhang, Yuying Li +1
Frontiers in Pharmacology5 Nov 2026Peer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
Reduced-dose nanoparticle albumin-bound-paclitaxel combined with ramucirumab as second-line treatment for advanced gastric cancer: a multicenter phase II study
Michihisa Iida, Chiyo Nakashima, Toru Kawaoka +13
BMC Cancer1 Jul 2026Peer-reviewedCC BYFull textOncologyDOAJ
Real-world effectiveness of polymeric micellar paclitaxel versus albumin-bound paclitaxel in advanced esophageal squamous cell carcinoma: a retrospective study
Weiping He, Lingli Chen, Shuangjia Huang +2
Nanomedicine29 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaPMC
Nanoparticle‐Mediated TIPE1 mRNA Delivery Enhances Paclitaxel Sensitivity in Triple‐Negative Breast Cancer by Modulating RAB7A Ubiquitination‐Associated Stability and Autophagy
Wei Hu, Qishuai Chen, Yan Ma +7
Advanced Science6 Aug 2026Peer-reviewedCC BY 4.0Full text1 citedEpidemiology & public healthPMC

Cite

BibTeX

@article{wang2026nanoparticle,
  title = {{Nanoparticle polymeric micellar paclitaxel (pm-Pac), platinum, and sintilimab as first-line treatment for advanced or metastatic non-squamous non-small cell lung cancer: a phase II study}},
  author = {Xiaohua Wang and Li Wang and Shaorong Yu and Danting Liao and Caolu Liu and Luan Li and Wei Peng and Xiaoxuan Wang and Xing Zhang and Zhen Guo and Xiaoyou Li and Xingwang Li and Xinnian Yu and Yun Zhou and Yiqun Tang and Meiqi Shi},
  journal = {BMC Medicine},
  year = {2026},
  month = oct,
  doi = {10.1186/s12916-026-05281-1},
  url = {https://link.springer.com/10.1186/s12916-026-05281-1},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Nanoparticle polymeric micellar paclitaxel (pm-Pac), platinum, and sintilimab as first-line treatment for advanced or metastatic non-squamous non-small cell lung cancer: a phase II study
AU  - Xiaohua Wang
AU  - Li Wang
AU  - Shaorong Yu
AU  - Danting Liao
AU  - Caolu Liu
AU  - Luan Li
AU  - Wei Peng
AU  - Xiaoxuan Wang
AU  - Xing Zhang
AU  - Zhen Guo
AU  - Xiaoyou Li
AU  - Xingwang Li
AU  - Xinnian Yu
AU  - Yun Zhou
AU  - Yiqun Tang
AU  - Meiqi Shi
PY  - 2026
DA  - 2026/10/01
JO  - BMC Medicine
DO  - 10.1186/s12916-026-05281-1
UR  - https://link.springer.com/10.1186/s12916-026-05281-1
SN  - 1741-7015
ER  -

Related

Cite